循环德克斯特林作为癌症治疗中的非病毒载体:一篇综述
Ge Qu1, Xu Han2, Lianghua Ma3
1Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, China.
International journal of biological macromolecules
|May 10, 2025
概括
循环德克斯特林 (CD) 是用于高级癌症治疗的多功能纳米粒子. 它们改善药物输送,增强免疫疗法,并有助于早期癌症诊断和生物标志物识别.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 癌症是导致死亡的主要原因,早期检测和治疗疗效受到无症状瘤和治疗耐药性的阻碍.
- 纳米粒子为改善癌症诊断和治疗结果提供了潜力.
- 循环德克斯特林 (CD) 是已知药剂,在治疗各种癌症中作为非病毒载体的有效性已被证明.
研究的目的:
- 探索循环德克斯特林 (CD) 在增强癌症诊断和治疗中的应用.
- 突出CDs在针对固体瘤和血液恶性瘤的向药物和基因输送中的作用.
- 研究刺激响应CD在瘤微环境 (TME) 中的潜力,以实现精确的有效载荷传递.
主要方法:
- 利用CD作为针对药物和基因传递的非病毒载体.
- 采用对刺激有反应的CD,对pH,氧化还原和光等TME因素做出反应.
- 将CD与光疗,化疗和免疫疗法相结合,以获得协同效应.
- 通过CDs使用免疫调节剂来增强免疫细胞透.
主要成果:
- 磁盘促进药物和基因的持续释放,提高治疗效率.
- 响应刺激的CD可以在TME内提供有针对性的有效载荷.
- CDs通过提高药物的可溶性和输送来增强光疗.
- 通过促进免疫细胞透,CDs改善了癌症免疫疗法.
结论:
- 循环德克斯作为癌症诊断和治疗的多功能平台显著有前途.
- 它们提高药物输送,免疫治疗和诊断能力的能力为改善患者预后提供了一条道路.
- 响应刺激的CD代表了TME中向癌症治疗的关键进步.
相关概念视频
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:30Cancer Vaccines
319
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
319
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K